# Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)

> **NCT06191848** · PHASE4 · RECRUITING · sponsor: **University of Melbourne** · enrollment: 352 (estimated)

## Conditions studied

- Obesity
- Knee Osteoarthritis
- Osteoarthritis, Knee

## Interventions

- **DRUG:** Tirzepatide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06191848
- **Lead sponsor:** University of Melbourne
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-19
- **Primary completion:** 2027-05
- **Final completion:** 2037-05
- **Target enrollment:** 352 (ESTIMATED)
- **Last updated:** 2025-04-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06191848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06191848, "Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06191848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*